SCHEMBL27488773

SCHEMBL27488773

O=CC1Nc2ccc(Br)cc2O1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AHR P35869 3/20 0.35
▸ TGM2 P21980 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ BLM P54132 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ PLA2G1B P04054 1/20 0.31
▸ GAPDH P04406 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ HSPA1A P0DMV8 1/20 0.31
▸ MIF P14174 1/20 0.31
▸ PTPN7 P35236 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31
▸ ATG4B Q9Y4P1 1/20 0.31
▸ PBRM1 Q86U86 1/20 0.31
▸ CYP2A6 P11509 2/20 0.31
▸ ERN1 O75460 1/20 0.31
▸ CA12 O43570 1/20 0.30
▸ CA2 P00918 1/20 0.30
▸ CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27668661 0.86 AHR (0.35) AHRBLMMEN1KMT2APBRM1
SCHEMBL27699002 0.79 TGM2 (0.33) TGM2CES1ERN1
SCHEMBL27590550 0.79 MAOB (0.33) KMT2AMAPT
SCHEMBL27539125 0.79 — —
SCHEMBL27859196 0.79 BRD4 (0.44) MIFTDP1CA2
SCHEMBL27590615 0.79 AHR (0.35) AHRTGM2CES1TDP1ERN1
SCHEMBL27590553 0.79 BRD4 (0.36) BLMMEN1GAPDHPOLBHSPA1A
SCHEMBL27590514 0.76 ALDH1A1 (0.37) HSPA1APTPN7ERN1CA2MAPT
SCHEMBL27539115 0.74 ALDH1A1 (0.43) MEN1GAPDHPOLBHSPA1APTPN7
SCHEMBL18885246 0.74 PARP1 (0.42) MEN1KMT2ACA2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100558428-C Calcitonin gene related peptide receptor antagonists BRISTOL MYERS SQUIBB CO (US) 2009-11-11 — — CN disclosed
CN-101242819-A Hypnotics and combinations of substituted biaryl and heteroaryl compounds and therapeutic uses thereof AVENTIS PHARMA INC (US) 2008-08-13 — — CN disclosed
CN-1917921-A Calcitonin gene related peptide receptor antagonists BRISTOL MYERS SQUIBB CO (US) 2007-02-21 — — CN disclosed
CN-1178911-C pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative diseases - 2004-12-08 — — CN disclosed
CN-1425002-A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders HOFFMANN LA ROCHE (CH) 2003-06-18 — — CN disclosed
Send feedback